Mediengine

About:

Mediengine develops drugs and materials for the treatment of metabolic diseases based on energy regulation.

Website: https://mediandgene.com

Top Investors: TIPS Program, Korea Investment Accelerator

Description:

Total Funding Amount:

1B KRW

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2021-01-01

Founders:

Number of Employees:

Last Funding Date:

2022-12-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai